An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19
- Resource Type
- Article
- Authors
- Fu, Weihui; Liu, Yan; Liu, Li; Hu, Huiliang; Cheng, Xiaobo; Liu, Ping; Song, Zhigang; Zha, Lijun; Bai, Shimeng; Xu, Tingting; Yuan, Songhua; Lu, Fengru; Shang, Zhiying; Zhao, Yihong; Wang, Jing; Zhao, Jun; Ding, Longfei; Chen, Jun; Zhang, Lin; Zhu, Tongyu; Zhang, Xiaoyan; Lu, Hongzhou; Xu, Jianqing
- Source
- In EClinicalMedicine October 2020 27
- Subject
- Language
- ISSN
- 2589-5370